Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
10.60 USD | +2.42% | +2.91% | +1.05% |
Nov. 07 | Transcript : Electromed, Inc., Q1 2024 Earnings Call, Nov 07, 2023 | CI |
Nov. 07 | Electromed, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023 | CI |
Financials (USD)
Sales 2024 * | 54.30 M | Sales 2025 * | - | Capitalization | 90.97 M |
---|---|---|---|---|---|
Net income 2024 * | 3.00 M | Net income 2025 * | - | EV / Sales 2024 * | 1,68x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * | 27,9x | P/E ratio 2025 * | Employees | 170 | |
Yield 2024 * | - | Yield 2025 * |
-
| Free-Float | 75.14% |
More Fundamentals
* Assessed data
More news
More press releases
1 day | +2.42% | ||
1 week | +2.91% | ||
Current month | +0.66% | ||
1 month | +1.92% | ||
3 months | -4.50% | ||
6 months | -11.67% | ||
Current year | +1.05% |
1 week
10.28
10.64

1 month
9.53
10.84

Current year
8.80
13.84

1 year
8.80
13.84

3 years
8.75
13.85

5 years
4.75
19.73

10 years
0.98
19.73

Managers | Title | Age | Since |
---|---|---|---|
Bradley Nagel
DFI | Director of Finance/CFO | 41 | Nov. 13 |
Kathleen Skarvan
CHM | Chairman | 67 | 2012 |
Kristine Owata
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathleen Skarvan
CHM | Chairman | 67 | 2012 |
Gregory Fluet
BRD | Director/Board Member | 54 | 2019 |
Kathleen Tune
BRD | Director/Board Member | 59 | 2021 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 678 M€ | -7.14% | ||
0.00% | 7,365 M€ | +6.21% | - | |
0.00% | 5,297 M€ | +4.38% | - | |
0.00% | 13,379 M€ | +10.93% | ||
0.00% | 30 M€ | +12.70% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-11-28 | 10.60 | +2.42% | 3,447 |
23-11-27 | 10.35 | -0.29% | 8,584 |
23-11-24 | 10.38 | +0.68% | 5,336 |
23-11-22 | 10.31 | +0.10% | 22,552 |
23-11-21 | 10.30 | 0.00% | 10,604 |
Delayed Quote Nyse, November 28, 2023 at 03:12 pm EST
More quotes
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The Company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The Company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Calendar
2024-02-12
- Q2 2024 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
C
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.60USD
Average target price
26.00USD
Spread / Average Target
+145.28%
EPS Revisions
1st Jan change | Capi. (M$) | |
---|---|---|
+1.05% | 91 M $ | |
-11.76% | 188 B $ | |
-17.58% | 162 B $ | |
+17.18% | 109 B $ | |
+18.72% | 80 472 M $ | |
+9.91% | 62 968 M $ | |
-9.93% | 48 160 M $ | |
-16.67% | 36 431 M $ | |
+16.70% | 31 016 M $ | |
-25.20% | 22 900 M $ |